516 related articles for article (PubMed ID: 20629551)
1. Evaluation of implants coated with recombinant human bone morphogenetic protein-2 and vacuum-dried using the critical-size supraalveolar peri-implant defect model in dogs.
Decker JF; Lee J; Cortella CA; Polimeni G; Rohrer MD; Wozney JM; Hall J; Susin C; Wikesjö UM
J Periodontol; 2010 Dec; 81(12):1839-49. PubMed ID: 20629551
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of implants coated with rhBMP-2 using two different coating strategies: a critical-size supraalveolar peri-implant defect study in dogs.
Lee J; Decker JF; Polimeni G; Cortella CA; Rohrer MD; Wozney JM; Hall J; Susin C; Wikesjö UM
J Clin Periodontol; 2010 Jun; 37(6):582-90. PubMed ID: 20345393
[TBL] [Abstract][Full Text] [Related]
3. Alveolar ridge augmentation using implants coated with recombinant human bone morphogenetic protein-7 (rhBMP-7/rhOP-1): histological observations.
Susin C; Qahash M; Polimeni G; Lu PH; Prasad HS; Rohrer MD; Hall J; Wikesjö UM
J Clin Periodontol; 2010 Jun; 37(6):574-81. PubMed ID: 20345394
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a compression resistant matrix for recombinant human bone morphogenetic protein-2.
Lu SX; Fiorini T; Lee J; Prasad HS; Buxton AN; Bisch FC; Dixon DR; Susin C; Wikesjö UM
J Clin Periodontol; 2013 Jul; 40(7):688-97. PubMed ID: 23627347
[TBL] [Abstract][Full Text] [Related]
5. Alveolar ridge augmentation using implants coated with recombinant human bone morphogenetic protein-2: histologic observations.
Wikesjö UM; Qahash M; Polimeni G; Susin C; Shanaman RH; Rohrer MD; Wozney JM; Hall J
J Clin Periodontol; 2008 Nov; 35(11):1001-10. PubMed ID: 18976397
[TBL] [Abstract][Full Text] [Related]
6. Effect of recombinant human bone morphogenetic protein-2 in dehiscence defects with non-submerged immediate implants: an experimental study in Cynomolgus monkeys.
Hanisch O; Sorensen RG; Kinoshita A; Spiekermann H; Wozney JM; Wikesjö UM
J Periodontol; 2003 May; 74(5):648-57. PubMed ID: 12816297
[TBL] [Abstract][Full Text] [Related]
7. Bone formation at recombinant human bone morphogenetic protein-2-coated titanium implants in the posterior mandible (Type II bone) in dogs.
Wikesjö UM; Xiropaidis AV; Qahash M; Lim WH; Sorensen RG; Rohrer MD; Wozney JM; Hall J
J Clin Periodontol; 2008 Nov; 35(11):985-91. PubMed ID: 18976395
[TBL] [Abstract][Full Text] [Related]
8. Recombinant human bone morphogenetic protein-2 stimulation of bone formation around endosseous dental implants.
Cochran DL; Schenk R; Buser D; Wozney JM; Jones AA
J Periodontol; 1999 Feb; 70(2):139-50. PubMed ID: 10102551
[TBL] [Abstract][Full Text] [Related]
9. Alveolar ridge augmentation using implants coated with recombinant human bone morphogenetic protein-7 (rhBMP-7/rhOP-1): radiographic observations.
Leknes KN; Yang J; Qahash M; Polimeni G; Susin C; Wikesjö UM
J Clin Periodontol; 2008 Oct; 35(10):914-9. PubMed ID: 18727659
[TBL] [Abstract][Full Text] [Related]
10. Impact of rhBMP-2 on regeneration of buccal alveolar defects during the osseointegration of transgingival inserted implants.
Smeets R; Maciejewski O; Gerressen M; Spiekermann H; Hanisch O; Riediger D; Blake F; Stein J; Hölzle F; Kolk A
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Oct; 108(4):e3-e12. PubMed ID: 19716715
[TBL] [Abstract][Full Text] [Related]
11. The critical-size supraalveolar peri-implant defect model: characteristics and use.
Wikesjö UM; Susin C; Qahash M; Polimeni G; Leknes KN; Shanaman RH; Prasad HS; Rohrer MD; Hall J
J Clin Periodontol; 2006 Nov; 33(11):846-54. PubMed ID: 16965525
[TBL] [Abstract][Full Text] [Related]
12. Radiographic analysis of regenerated bone around endosseous implants in the canine using recombinant human bone morphogenetic protein-2.
Cochran DL; Nummikoski PV; Jones AA; Makins SR; Turek TJ; Buser D
Int J Oral Maxillofac Implants; 1997; 12(6):739-48. PubMed ID: 9425754
[TBL] [Abstract][Full Text] [Related]
13. Alveolar ridge augmentation with rhBMP-2 and bone-to-implant contact in induced bone.
Sigurdsson TJ; Nguyen S; Wikesjo UM
Int J Periodontics Restorative Dent; 2001 Oct; 21(5):461-73. PubMed ID: 11693239
[TBL] [Abstract][Full Text] [Related]
14. Bone formation and reosseointegration in peri-implantitis defects following surgical implantation of rhBMP-2.
Hanisch O; Tatakis DN; Boskovic MM; Rohrer MD; Wikesjö UM
Int J Oral Maxillofac Implants; 1997; 12(5):604-10. PubMed ID: 9337020
[TBL] [Abstract][Full Text] [Related]
15. Bone formation at recombinant human bone morphogenetic protein-2-coated titanium implants in the posterior maxilla (Type IV bone) in non-human primates.
Wikesjö UM; Huang YH; Xiropaidis AV; Sorensen RG; Rohrer MD; Prasad HS; Wozney JM; Hall J
J Clin Periodontol; 2008 Nov; 35(11):992-1000. PubMed ID: 18976396
[TBL] [Abstract][Full Text] [Related]
16. Alveolar ridge augmentation using anodized implants coated with Escherichia coli-derived recombinant human bone morphogenetic protein 2.
Huh JB; Park CK; Kim SE; Shim KM; Choi KH; Kim SJ; Shim JS; Shin SW
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Jul; 112(1):42-9. PubMed ID: 21194992
[TBL] [Abstract][Full Text] [Related]
17. Space-providing expanded polytetrafluoroethylene devices define alveolar augmentation at dental implants induced by recombinant human bone morphogenetic protein 2 in an absorbable collagen sponge carrier.
Wikesjö UM; Qahash M; Thomson RC; Cook AD; Rohrer MD; Wozney JM; Hardwick WR
Clin Implant Dent Relat Res; 2003; 5(2):112-23. PubMed ID: 14536046
[TBL] [Abstract][Full Text] [Related]
18. Surface-etching enhances titanium implant osseointegration in newly formed (rhBMP-2-induced) and native bone.
Qahash M; Hardwick WR; Rohrer MD; Wozney JM; Wikesjö UM
Int J Oral Maxillofac Implants; 2007; 22(3):472-7. PubMed ID: 17622015
[TBL] [Abstract][Full Text] [Related]
19. Comparative study of Chinese hamster ovary cell versus Escherichia coli-derived bone morphogenetic protein-2 using the critical-size supraalveolar peri-implant defect model.
Lee J; Lee EN; Yoon J; Chung SM; Prasad H; Susin C; Wikesjö UM
J Periodontol; 2013 Mar; 84(3):415-22. PubMed ID: 22612368
[TBL] [Abstract][Full Text] [Related]
20. Alveolar ridge augmentation using implants coated with recombinant human growth/differentiation factor-5: histologic observations.
Polimeni G; Wikesjö UM; Susin C; Qahash M; Shanaman RH; Prasad HS; Rohrer MD; Hall J
J Clin Periodontol; 2010 Aug; 37(8):759-68. PubMed ID: 20500538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
